Marc Pelletier

British Columbia Ferry Services, Inc. engages in the provision of coastal ferry services. It connects coastal communities and facilitates the movement of people, goods, and services. The firm focuses on Skeena Queen mid-life upgrade, pacific buffet - beer and wine pilot, ferries for the next generation, BC Ferries' island class, smoke-free environment, horseshoe bay terminal engagement, and lower closed vehicle deck access onboard projects. The company was founded in 1960 and is headquartered in Victoria, Canada.

Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada.

The Michael Smith Foundation for Health Research operates as a health research funding agency. The non-profit company is based in Vancouver, Canada. Diane Finegood has been the CEO of the Canadian company since 2012.

Pacific Blue Cross is a non-profit health benefits society based in Burnaby, BC, and is the number one health benefits provider in British Columbia. The Canadian company offers health, dental, life, disability, and travel coverage for 1 in 3 British Columbians through group benefits and individual plans. The non-profit company also supports charitable organizations across the province working to improve health outcomes. Pacific Blue Cross provides exceptional coverage, personalized plans, and unparalleled customer service, all tailored to the unique needs of their clients. The company offers resources for group plan advisors and information regarding their services. Choosing health coverage is not difficult with Pacific Blue Cross, and they encourage individuals to consider all of their options and make an informed decision about their coverage.

Canadian Partnership Against Cancer initiates and implements cancer control programs. It offers prevention and screening; diagnosis and clinical care; person-centered perspective; research; system performance; knowledge management; and public engagement and outreach. The company is headquartered in Toronto, Canada.

BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.

Doctors of BC operates as a voluntary association of physicians, residents and medical students in British Columbia. The company was founded in January 1900 and is headquartered in Vancouver, Canada.

Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA.

BCAA Insurance Corp. provides roadside assistance, car, home, and travel insurance. The private company is based in Burnaby, Canada. The Canadian company offers exclusive insurance savings and member benefits to those who join BCAA. The company was founded in 1906, and the CEO is Eric Hopkins.

Technical Safety BC engages in the provision of installation and operation of technical systems and equipment across the province. It offers electrical equipment and systems, amusement devices, boilers, pressure vessels, and refrigeration systems. The company was founded in 2004 and is headquartered in New Westminster, Canada.

Part of Premier Diversified Holdings, Inc., Premier Diagnostic Center (Vancouver), Inc. engages in providing, designing and operating advanced nuclear medicine diagnostic imaging services. The company is based in Vancouver, Canada. The CEO of the Canadian company is Simon Sutcliffe.

Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.

Bold Therapeutics, Inc. is a Canadian clinical-stage biopharmaceutical company that was founded in 2018 by a team of industry veterans to develop and commercialize novel therapeutics. The company is based in Vancouver, Canada. The company's focus is on developing Bold-100, a drug that has the potential to significantly improve outcomes in a wide range of both solid and liquid tumors in combination with other anticancer therapies. Edward Russell McAllister has been the CEO of the company since 2018.